조영미 부교수
#신장병리#비뇨생식계병리
|
학력
2000 .08 ~ 2003 .06인디애나주립대학 의학 박사
1993 .03 ~ 1997 .02울산대학교 의학 석사
1985 .03 ~ 1991 .02경북대학교 의학 학사
1993 .03 ~ 1997 .02울산대학교 의학 석사
1985 .03 ~ 1991 .02경북대학교 의학 학사
경력
2010 .04 ~ 현재울산의대 서울아산병원, 부교수
2005 .03 ~ 2010 .03울산의대 서울아산병원, 조교수
2004 .03 ~ 2005 .02서울아산병원 임상전임강사
2003 .07 ~ 2004 .02서울아산병원 임상강사
1999 .08 ~ 2003 .05인디아나대 연구원
1999 .03 ~ 1999 .06경북대의대 임상교수
1997 .03 ~ 1999 .02경산동산병원 과장
1996 .03 ~ 1997 .02서울아산병원 임상강사
1992 .03 ~ 1996 .02서울아산병원 전공의
1991 .03 ~ 1992 .02서울아산병원 인턴
2005 .03 ~ 2010 .03울산의대 서울아산병원, 조교수
2004 .03 ~ 2005 .02서울아산병원 임상전임강사
2003 .07 ~ 2004 .02서울아산병원 임상강사
1999 .08 ~ 2003 .05인디아나대 연구원
1999 .03 ~ 1999 .06경북대의대 임상교수
1997 .03 ~ 1999 .02경산동산병원 과장
1996 .03 ~ 1997 .02서울아산병원 임상강사
1992 .03 ~ 1996 .02서울아산병원 전공의
1991 .03 ~ 1992 .02서울아산병원 인턴
논문
Prognostic Significance of Macroscopic Appearance in Clear Cell Renal Cell Carcinoma and Its Metastasis-Predicting Model.
Clinicopathologic Characteristics and Mutational Status of Succinate Dehydrogenase Genes in Paraganglioma of the Urinary Bladder: A Multi-Institutional Korean Study.
Staphylococcus-Associated Glomerulonephritis
Clinical Significance of Substaging and HER2 Expression in Papillary Nonmuscle Invasive Urothelial Cancers of the Urinary Bladder.
Clinicopathologic Analysis of PD-L1 and PD-L2 Expression in Renal Cell Carcinoma: Association with Oncogenic Proteins Status.
Clinicopathological features of prostate ductal carcinoma: matching analysis and comparison with prostate acinar carcinoma.
Expression of Peroxisome Proliferator Activated Receptor gamma in Prostatic Adenocarcinoma.
Histological and immunohistochemical markers for progression prediction in transurethrally resected high-grade non-muscle invasive bladder cancer.
Immunoprofile-based subgrouping of urothelial bladder carcinomas for survival prediction.
Interpreting CD56+ and CD163+ infiltrates in early versus late renal transplant biopsies.
Mesenchymal Stem Cell Therapy Alleviates Interstitial Cystitis by Activating Wnt Signaling Pathway.
Prognostic significance of platelet-derived growth factor receptor-β expression in localized clear cell renal cell carcinoma.
Reduction in Renal Ischemia-Reperfusion Injury in Mice by a Phosphoinositide 3-Kinase p110gamma-Specific Inhibitor.
Sphingosine-1-phosphate receptor 1 (S1PR1) expression in non-muscle invasive urothelial carcinoma: Association with poor clinical outcome and potential therapeutic target.
The Association Between PD-L1 Expression and the Clinical Outcomes to Vascular Endothelial Growth Factor-Targeted Therapy in Patients With Metastatic Clear Cell Renal Cell Carcinoma.
miR-93/miR-106b/miR-375-CIC-CRABP1: a novel regulatory axis in prostate cancer progression.
AZGP-1 immunohistochemical marker in prostate cancer: potential predictive marker of biochemical recurrence in post radical prostatectomy specimens.
Conventional Cisplatin-Based Combination Chemotherapy Is Effective in the Treatment of Metastatic Spermatocytic Seminoma with Extensive Rhabdomyosarcomatous Transformation.
Hepatoid differentiation in renal cell carcinoma: a rare histologic pattern with clinical significance.
Non-crossing weighted kernel quantile regression with right censored data.
Sarcomatoid features, necrosis, and grade are prognostic factors in metastatic clear cell renal cell carcinoma with vascular endothelial growth factor-targeted therapy.
The paracrine effects of mesenchymal stem cells stimulate the regeneration capacity of endogenous stem cells in the repair of a bladder-outlet-obstruction-induced overactive bladder.
VEGF/VEGFR2 and PDGF-B/PDGFR-β expression in non-metastatic renal cell carcinoma: a retrospective study in 1,091 consecutive patients.
Adult Dual Kidney Transplantation Obtained From Marginal Donors: Two Case Reports
Expression of stem-cell markers OCT-4 and CD133: important prognostic factors in papillary renal cell carcinoma.
Histology and distribution of prostatic tissue on prostatic urethral margins: evaluation of radical prostatectomy specimens and implications on frozen section analysis
Long-term recovery of irradiated prostate cancer increases cancer stem cells
Multicenter phase II study of sunitinib in patients with non-clear cell renal cell carcinoma
Post-transplant lymphoproliferative disorders: clinicopathological analysis of 43 cases in a single center, 1990-2009.
Type II papillary histology predicts poor outcome in patients with renal cell carcinoma and vena cava thrombus.
Clinicopathologic Characteristics and Mutational Status of Succinate Dehydrogenase Genes in Paraganglioma of the Urinary Bladder: A Multi-Institutional Korean Study.
Staphylococcus-Associated Glomerulonephritis
Clinical Significance of Substaging and HER2 Expression in Papillary Nonmuscle Invasive Urothelial Cancers of the Urinary Bladder.
Clinicopathologic Analysis of PD-L1 and PD-L2 Expression in Renal Cell Carcinoma: Association with Oncogenic Proteins Status.
Clinicopathological features of prostate ductal carcinoma: matching analysis and comparison with prostate acinar carcinoma.
Expression of Peroxisome Proliferator Activated Receptor gamma in Prostatic Adenocarcinoma.
Histological and immunohistochemical markers for progression prediction in transurethrally resected high-grade non-muscle invasive bladder cancer.
Immunoprofile-based subgrouping of urothelial bladder carcinomas for survival prediction.
Interpreting CD56+ and CD163+ infiltrates in early versus late renal transplant biopsies.
Mesenchymal Stem Cell Therapy Alleviates Interstitial Cystitis by Activating Wnt Signaling Pathway.
Prognostic significance of platelet-derived growth factor receptor-β expression in localized clear cell renal cell carcinoma.
Reduction in Renal Ischemia-Reperfusion Injury in Mice by a Phosphoinositide 3-Kinase p110gamma-Specific Inhibitor.
Sphingosine-1-phosphate receptor 1 (S1PR1) expression in non-muscle invasive urothelial carcinoma: Association with poor clinical outcome and potential therapeutic target.
The Association Between PD-L1 Expression and the Clinical Outcomes to Vascular Endothelial Growth Factor-Targeted Therapy in Patients With Metastatic Clear Cell Renal Cell Carcinoma.
miR-93/miR-106b/miR-375-CIC-CRABP1: a novel regulatory axis in prostate cancer progression.
AZGP-1 immunohistochemical marker in prostate cancer: potential predictive marker of biochemical recurrence in post radical prostatectomy specimens.
Conventional Cisplatin-Based Combination Chemotherapy Is Effective in the Treatment of Metastatic Spermatocytic Seminoma with Extensive Rhabdomyosarcomatous Transformation.
Hepatoid differentiation in renal cell carcinoma: a rare histologic pattern with clinical significance.
Non-crossing weighted kernel quantile regression with right censored data.
Sarcomatoid features, necrosis, and grade are prognostic factors in metastatic clear cell renal cell carcinoma with vascular endothelial growth factor-targeted therapy.
The paracrine effects of mesenchymal stem cells stimulate the regeneration capacity of endogenous stem cells in the repair of a bladder-outlet-obstruction-induced overactive bladder.
VEGF/VEGFR2 and PDGF-B/PDGFR-β expression in non-metastatic renal cell carcinoma: a retrospective study in 1,091 consecutive patients.
Adult Dual Kidney Transplantation Obtained From Marginal Donors: Two Case Reports
Expression of stem-cell markers OCT-4 and CD133: important prognostic factors in papillary renal cell carcinoma.
Histology and distribution of prostatic tissue on prostatic urethral margins: evaluation of radical prostatectomy specimens and implications on frozen section analysis
Long-term recovery of irradiated prostate cancer increases cancer stem cells
Multicenter phase II study of sunitinib in patients with non-clear cell renal cell carcinoma
Post-transplant lymphoproliferative disorders: clinicopathological analysis of 43 cases in a single center, 1990-2009.
Type II papillary histology predicts poor outcome in patients with renal cell carcinoma and vena cava thrombus.
저서
저서 내용이 없습니다.
보도자료
[주간연구동향] 한국 연구진, 방광암 발전 ‘암 줄기세포’ 병리기전 규명
http://www.econovill.com/news/articleView.html?idxno=379544
http://www.econovill.com/news/articleView.html?idxno=379544
포스팅
Epithelial-mesenchymal transition as a mechanism of acquired tyrosine kinase inhibitor resistance in clear cell renal cell carcinoma
Molecular Subgrouping and Prognosis Prediction Using Immunoprofile of Urothelial Carcinoma
Papillary renal cell carcinoma (pRCC) subclassfication as a prognostic factor: comparison of type I and II pRCC with clear cell RCC and chromophobe RCC
VEGF/VEGFR2 or PDGF-β/PDGFR-β expression in non-metastatic, renal cell carcinoma : a prospective study with 1,091 consecutive cases
Clinical characteristics, survival and prognostic factors of advanced renal cell carcinoma with predominant sarcomatoid histology
Role of molecular markers in nephrectomyspecimenas prognosticators for patients with metastatic renal cell carcinomain the era of targeted therapy
Papillary urothelial carcinoma with urothelial eddy formation: A distinct morphologic pattern with low risk for progression
Molecular Subgrouping and Prognosis Prediction Using Immunoprofile of Urothelial Carcinoma
Papillary renal cell carcinoma (pRCC) subclassfication as a prognostic factor: comparison of type I and II pRCC with clear cell RCC and chromophobe RCC
VEGF/VEGFR2 or PDGF-β/PDGFR-β expression in non-metastatic, renal cell carcinoma : a prospective study with 1,091 consecutive cases
Clinical characteristics, survival and prognostic factors of advanced renal cell carcinoma with predominant sarcomatoid histology
Role of molecular markers in nephrectomyspecimenas prognosticators for patients with metastatic renal cell carcinomain the era of targeted therapy
Papillary urothelial carcinoma with urothelial eddy formation: A distinct morphologic pattern with low risk for progression
영상자료
영상자료 내용이 없습니다.
발표자료
미세혈관병증 용혈성빈혈을 동반한 경쇄침착질환 1예
The clinicopathologic features of Korean prostate cancer
Papillary renal cell carcinomas with inverted and micropapillary patterns and their clinicopathologic features.
Immunohistochemical markers for metastatic renal cell carcinoma
The clinicopathologic features of Korean prostate cancer
Papillary renal cell carcinomas with inverted and micropapillary patterns and their clinicopathologic features.
Immunohistochemical markers for metastatic renal cell carcinoma